Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 146 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Determinants of health-related quality of life in a multinational systemic sclerosis inception cohortMorrisroe, K.; Hudson, M.; Baron, M.; De Vries-Bouwstra, J.; Carreira, P.; Wuttge, D.; Wang, M.; Frech, T.; Stevens, W.; Proudman, S.; Nikpour, M.
2012Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low doseProudman, S.; Spargo, L.; Hall, C.; McWilliams, L.; Lee, A.; Rischmueller, M.; Gibson, R.; James, M.; Cleland, L.; Australian Rheumatology Association Annual Scientific Meeting (2012 : Canberra, A.C.T.)
2014Cardiac arrhythmias and conduction defects in systemic sclerosisVacca, A.; Meune, C.; Gordon, J.; Chung, L.; Proudman, S.; Assassi, S.; Nikpour, M.; Rodriguez-Reyna, T.; Khanna, D.; Lafyatis, R.; Matucci-Cerinic, M.; Distler, O.; Allanore, Y.
2019Defining primary systemic sclerosis heart involvement: a scoping literature reviewRoss, L.; Prior, D.; Proudman, S.; Vacca, A.; Baron, M.; Nikpour, M.
2015Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritisMoghaddami, M.; James, M.; Proudman, S.; Cleland, L.
2005Isolated pulmonary hypertension in sclerodermaCox, S.; Walker, J.; Coleman, M.; Rischmueller, M.; Proudman, S.; Smith, M.; Ahern, M.; Roberts-Thomson, P.
2017Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritisHopkins, A.; Wiese, M.; O Doherty, C.; Proudman, S.
2016Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort studyMorrisroe, K.; Huq, M.; Stevens, W.; Rabusa, C.; Proudman, S.; Nikpour, M.; The Australian Scleroderma Interest Group (ASIG)
2016Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?Wabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Hall, C.; Spargo, L.; Metcalf, R.; Proudman, S.; Wiese, M.
2012Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysisGraf, S.; Lester, S.; Nossent, J.; Hill, C.; Proudman, S.; Lee, A.; Rischmueller, M.